A randomized, controlled clinical study to compare efficacy of a polyherbal formulation (GP/PROD/2021/004) versus Standard Allopathic Formulation for relief of acutenonproductive cough and throat irritation - Nil

Mr Kamlesh Thummar0 个研究点目标入组 66 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•Patients with H/O acute nonproductive cough and throat irritation for less than 1week duration
•Males and Females between 18-65 years age
•Patients who in the opinion of the Investigator will be able to comply with the study requirements
•Patients with a cough score of 0, 1 or 2 during day time
•Patients willing and able to provide signed informed consent for any study related procedures.

•Patients with H/O lower respiratory tract infections such as Pneumonia, Tuberculosis, Bronchitis, Whooping cough.
•Patients with H/O Chronic Obstructive Pulmonary
•Diseases/Asthma
•Patients with H/O underlying lung pathology such as lung abscess, cystic fibrosis.
•Patients with known hypersensitivity to ingredients of Investigational Products
•Patients with clinical suspicion of any systemic bacterial infection.
•Patients with H/O Myocardial Infarction (MI) within 4 weeks prior to enrollment
•Patients with immediate life threatening diseases such as pre-existing cardiovascular, liver or neoplastic disease.

发起方

Mr Kamlesh Thummar